Perspective Therapeutics CATX
NYSE CATX
$3.22 -0.26 (-7.47%)
As of: Aug 20, 2026 · 3:59 PM EDT

Perspective Therapeutics (CATX) FCF Margin (QoQ) (2010 - 2023)

Perspective Therapeutics (CATX) FCF Margin (QoQ) (2010 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 Perspective Therapeutics 389.10 Mn 389.10 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 65,867.00
Sep 30, 2023 10,204.00
Jun 30, 2023 -9,409.00
Sep 30, 2022 -621.00
Jun 30, 2022 -3,228.00
Mar 31, 2022 -14,809.00
Dec 31, 2021 18,165.00
Mar 31, 2021 730.00
Dec 31, 2020 -1,584.00
Sep 30, 2020 1,939.00
Jun 30, 2020 -685.00
Mar 31, 2020 3,128.00
Dec 31, 2019 -3,030.00
Sep 30, 2019 2,348.00
Jun 30, 2019 2,027.00
Mar 31, 2019 -1,186.00
Dec 31, 2018 4,616.00
Sep 30, 2018 -1,356.00
Jun 30, 2018 -2,314.00
Mar 31, 2018 3,160.00